Stay updated on Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Locations section with a Washington listing and updated the revision to v3.3.3. Removed the older Washington Locations header and the HHS Vulnerability Disclosure section.
    Difference
    0.2%
    Check dated 2025-12-23T12:36:39.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor metadata updates: a PubMed-related note was added and the page revision 3.3.2 is listed, while the PubMed description was shortened and the previous revision 3.2.0 is no longer shown. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:03:38.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the government funding notice about updates and operating status; the study details content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T15:03:53.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Minor formatting differences observed between the two screenshots, with core study details (title, eligibility criteria, endpoints, and enrollment) unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:34:54.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Major change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.
    Difference
    2%
    Check dated 2025-10-05T14:18:44.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    - Added: Revision: v3.1.0. - Removed: Head and neck squamous cell carcinoma. - Removed: Revision: v3.0.2 to align versioning with the new update.
    Difference
    0.5%
    Check dated 2025-09-28T09:43:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.